Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Jan 27, 2025; 17(1): 100910
Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.100910
Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.100910
Parameters | All | No LARS, % | Minor LARS, % | Major LARS, % | P | ||
No vs minor | No vs major | Minor vs major | |||||
Patients | 186 | 26 (13.98) | 109 (58.6) | 51 (27.42) | |||
Age in years | 59.35 ± 10.28 | 69.85 ± 8.03 | 60.51 ± 8.84 | 52.47 ± 9.14 | < 0.001 | < 0.001 | < 0.001 |
Sex | 0.029 | 0.026 | < 0.001 | ||||
Male | 129 (69.35) | 23 (12.37) | 73 (39.25) | 33 (17.74) | |||
Female | 57 (30.65) | 3 (1.61) | 36 (19.35) | 18 (9.68) | |||
TME/PME | < 0.001 | < 0.001 | < 0.001 | ||||
TME | 82 (44.09) | 0 (0) | 34 (18.28) | 48 (25.81) | |||
PME | 104 (55.91) | 26 (13.98) | 75 (40.32) | 3 (1.61) | |||
Tumor height in cm | 9.08 ± 3.32 | 13.69 ± 2.02 | 9.44 ± 2.60 | 6.08 ± 1.87 | < 0.001 | < 0.001 | < 0.001 |
Stoma | 86 (46.24) | 3 (1.61) | 37 (19.89) | 46 (24.73) | 0.024 | < 0.001 | < 0.001 |
Preoperative radiotherapy | 51 (27.42) | 0 (0) | 17 (9.14) | 34 (18.28) | 0.043 | < 0.001 | < 0.001 |
C30 scales | No LARS | Minor LARS | Major LARS | P | ||
No vs minor | No vs major | Minor vs major | ||||
Total | 26 (13.98) | 109 (58.60) | 51 (27.42) | |||
PF | 87.69 ± 17.96 | 88.38 ± 16.16 | 88.37 ± 12.35 | 0.836 | 0.627 | 0.571 |
RF | 89.74 ± 17.69 | 85.63 ± 21.33 | 83.99 ± 19.99 | 0.303 | 0.163 | 0.47 |
EF | 88.78 ± 17.79 | 88.46 ± 15.63 | 87.25 ± 13.16 | 0.773 | 0.284 | 0.243 |
CF | 91.03 ± 15.08 | 87.31 ± 15.37 | 86.27 ± 15.88 | 0.184 | 0.154 | 0.713 |
SF | 83.33 ± 25.39 | 81.80 ± 21.58 | 73.53 ± 20.05 | 0.386 | 0.018 | 0.007 |
Fatigue | 21.37 ± 21.30 | 24.87 ± 22.17 | 28.32 ± 20.53 | 0.473 | 0.118 | 0.215 |
Nausea and vomiting | 1.92 ± 5.43 | 2.29 ± 7.34 | 2.29 ± 7.47 | 0.963 | 0.863 | 0.851 |
Pain | 8.33 ± 19.58 | 7.49 ± 13.89 | 11.44 ± 17.79 | 0.503 | 0.157 | 0.166 |
Dyspnea | 3.85 ± 10.86 | 7.03 ± 14.40 | 8.50 ± 16.12 | 0.304 | 0.204 | 0.613 |
Sleep disturbance | 10.26 ± 15.69 | 18.96 ± 25.40 | 16.99 ± 23.45 | 0.153 | 0.309 | 0.688 |
Appetite loss | 8.97 ± 15.08 | 8.56 ± 15.32 | 5.23 ± 13.94 | 0.841 | 0.176 | 0.125 |
Constipation | 20.51 ± 26.79 | 27.52 ± 26.00 | 20.26 ± 25.01 | 0.157 | 0.938 | 0.069 |
Diarrhea | 12.82 ± 19.04 | 16.51 ± 19.58 | 24.18 ± 22.19 | 0.354 | 0.027 | 0.036 |
Financial impact | 11.54 ± 16.17 | 17.74 ± 24.67 | 28.10 ± 30.82 | 0.382 | 0.028 | 0.044 |
Global quality of life | 66.35 ± 27.54 | 69.50 ± 23.47 | 68.95 ± 18.71 | 0.767 | 0.965 | 0.67 |
CR29 scales | No LARS | Minor LARS | Major LARS | P | ||
No vs minor | No vs major | Minor vs major | ||||
Total | 26 (13.98) | 109 (58.60) | 51 (27.42) | |||
Urinary frequency | 16.03 ± 19.14 | 16.82 ± 18.36 | 13.07 ± 13.87 | 0.782 | 0.764 | 0.36 |
Blood and mucus in stool | 3.21 ± 6.70 | 6.57 ± 11.12 | 10.78 ± 13.26 | 0.167 | 0.01 | 0.038 |
Body image | 14.53 ± 18.53 | 15.09 ± 15.68 | 19.83 ± 14.96 | 0.463 | 0.068 | 0.022 |
Flatulence | 25.76 ± 30.74 | 28.18 ± 28.60 | 34.67 ± 27.73 | 0.623 | 0.163 | 0.137 |
Fecal incontinence | 13.04 ± 26.09 | 18.75 ± 23.60 | 30.61 ± 28.74 | 0.145 | 0.006 | 0.013 |
Sore skin | 1.52 ± 7.11 | 6.25 ± 14.76 | 8.67 ± 17.57 | 0.143 | 0.067 | 0.416 |
Stool frequency | 23.91 ± 29.23 | 23.20 ± 20.91 | 34.69 ± 20.37 | 0.703 | 0.039 | 0.002 |
Embarrassment | 21.21 ± 37.86 | 32.64 ± 31.71 | 40.28 ± 33.66 | 0.046 | 0.012 | 0.215 |
Sexual interest (men) | 21.05 ± 25.36 | 19.44 ± 23.57 | 23.53 ± 25.33 | 0.796 | 0.707 | 0.384 |
Impotence | 11.76 ± 20.21 | 23.23 ± 29.22 | 28.13 ± 35.02 | 0.137 | 0.128 | 0.667 |
Sexual interest (women) | 1 | 1 | 1 | |||
Dyspareunia | 1 | 1 | 1 | |||
Urinary incontinence | 2.56 ± 9.06 | 5.50 ± 13.24 | 1.31 ± 6.53 | 0.295 | 0.484 | 0.033 |
Dysuria | 5.13 ± 15.47 | 2.14 ± 8.21 | 1.96 ± 7.92 | 0.35 | 0.366 | 0.896 |
Abdominal pain | 7.69 ± 14.32 | 6.73 ± 14.89 | 9.15 ± 16.44 | 0.619 | 0.784 | 0.308 |
Buttock pain | 6.41 ± 18.90 | 6.73 ± 15.57 | 11.76 ± 20.90 | 0.548 | 0.116 | 0.088 |
Bloating | 16.67 ± 21.60 | 10.09 ± 16.67 | 11.11 ± 18.46 | 0.134 | 0.244 | 0.842 |
Dry mouth | 12.82 ± 19.04 | 19.57 ± 20.39 | 20.26 ± 23.17 | 0.111 | 0.18 | 0.976 |
Hair loss | 6.41 ± 13.40 | 12.23 ± 22.53 | 12.42 ± 18.81 | 0.316 | 0.177 | 0.577 |
Taste | 8.97 ± 17.78 | 3.67 ± 10.48 | 5.88 ± 14.46 | 0.094 | 0.421 | 0.385 |
Anxiety | 23.08 ± 26.28 | 27.52 ± 25.19 | 32.03 ± 26.63 | 0.383 | 0.157 | 0.304 |
Weight | 11.54 ± 18.72 | 16.51 ± 22.96 | 15.69 ± 21.45 | 0.355 | 0.43 | 0.924 |
Parameter | POLARS score | Total | |||
No LARS | Minor LARS | Major LARS | |||
Actual LARS score | No LARS | 10 | 25 | 3 | 38 |
Minor LARS | 6 | 19 | 6 | 31 | |
Major LARS | 10 | 65 | 42 | 117 | |
Total | 26 | 109 | 51 | 186 |
- Citation: Pan YT, Lv YM, Zhou SC, Luo DY, Sun H, Lao WF, Zhou W. Evaluation of surgical strategy for low anterior resection syndrome using preoperative low anterior resection syndrome score in China. World J Gastrointest Surg 2025; 17(1): 100910
- URL: https://www.wjgnet.com/1948-9366/full/v17/i1/100910.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i1.100910